Addition of High-Dose Vitamin D 3 to Standard Treatment for Metastatic Colorectal Cancer

Дата публикации: 03-08-2026 00:00:00

This randomized clinical trial assesses whether high-dose vitamin D3, compared with standard-dose vitamin D3, added to standard chemotherapy improves progression-free survival in patients in the US National Clinical Trials Network with previously untreated metastatic colorectal cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Vitamin D boosts breast cancer treatment success by 79%	0	8.57	28-04-2026
2	Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases	0	7	03-07-2026
3	Chugai Files for Additional Indication of Tecentriq for Adjuvant Treatment of MSI-High Colon Cancer	0	13.47	14-08-2026
4	No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk Patients Identified Through ctDNA-based MRD Assessment After CRC Resection	0	5	22-06-2026
5	Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery	0	7	03-07-2026
6	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
7	Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer	0	14.28	01-01-2025
8	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer	0	18.85	30-07-2026
9	Минздрав разрешил онкобольным участвовать в исследованиях "Эпиваккороны" и "Ковивака"	0	0	14-04-2021

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 13.41. Источник: archderm.jamanetwork.com.